Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.30) by 4.92 percent. This is a 45.28 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $31.109 million which beat the analyst consensus estimate of $26.471 million by 17.52 percent. This is a 25.92 percent increase over sales of $24.705 million the same period last year.